Episode 11: Rapamycin, Biological Clocks & the Future of Longevity | Matt Kaeberlein
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original language
In this episode of Biopeak Live, hosts Prof Deepak Saini and Mr Prashanth Prakash are joined by Prof Matt Kaeberlein for a wide-ranging conversation on the current state and future of longevity science.
Matt reflects on his journey from academia into entrepreneurship and the challenges that shaped projects like the Dog Aging Project and Ora Biomedical
The discussion explores mTOR biology, Rapamycin, caloric restriction, biological clocks, AI-driven discovery, and the limitations of the “hallmarks of aging” framework.
Matt also shares his views on supplement hype, the promise and pitfalls of biological age testing, and why large-scale unbiased discovery science may be key to unlocking the next era of longevity research.
Timestamps
00:00 – Introduction
01:03 – Matt Kaeberlein’s journey into aging research
04:09 – Early aging biology research
06:47 – Academia vs startups
11:31 – mTOR and Rapamycin
14:37 – Hallmarks of Aging
15:30 – AI and aging iology
21:20 – Discovery science and intervention screening
24:23 – WormBot and Million Molecule Challenge
29:17 – Caloric restriction and combination therapies
34:38 – Rapamycin trials in India
41:16 – Longevity biomarkers and clinical trials
47:34 – Preventative longevity medicine
50:30 – Supplements and longevity hype
54:29 – Biological clocks and epigenetic testing
About Matt Kerberlein
Matt Kaeberlein, Professor at the University of Washington, and Co-Director of the Dog Aging Project. His research focuses on understanding the biological mechanisms of aging and developing interventions to improve healthspan in both humans and companion animals.
He has published over 250 scientific papers in aging biology and is a Fellow of the AAAS, AGE, and GSA. Dr. Kaeberlein has received several major awards in gerontology and previously served as Director of the University of Washington Healthy Aging and Longevity Research Institute and the NIH Nathan Shock Center of Excellence in the Basic Biology of Aging.
Longevity India · 58 min · Source published: 2026-05-25
Added to Harbor: 10/22/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.